GRM1 and cancer: 26% of the expression variation of CPEB1 that regulates synaptic plasticity and is implied in cancer development [58] and GRM1 that is involved in neurotransmitter in the central nervous system and implicated in melanoma [59] was explained by overexpressed mir-25 and mir-15b, respectively.